Halozyme Therapeutics (HALO)

Common Shares
Sell: $69.43|Buy: $71.35|Change: 3.01 (4.47%)

Cash flow

Operating cash flow
Taxation
Investing activities
Financing
Foreign exchange adjustments
Opening balance